Hyundai Pharmaceutical Co., Ltd. (004310.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 95.79B |
| Enterprise Value | 143.35B |
| P/E Ratio | 35.92 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.68 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 0.89 |
| Enterprise/EBITDA | 15.68 |
Fiscal Year
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | May 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 191.79B |
| Revenue/Share | 6,544.57 |
| Gross Profit | 78.23B |
| EBITDA | 7.58B |
| Net Income | 2.52B |
| Diluted EPS | 96.28 |
Balance Sheet
| Total Cash | 18.72B |
| Total Cash/Share | 605.4 |
| Total Debt | 49.91B |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.69 |
| Book Value Per Share | 4,141.78 |
Price History
| 52-Week Change | 46.62 |
| 52-Week High | 15,960 |
| 52-Week Low | 3,500 |
| Moving Average 50 Days | 6,157.8 |
| Moving Average 200 Days | 7,814.43 |
Statistics
| Average Volume | 4.14M |
| Shares Outstanding | 23.45M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 30 |
| Trailing Annual Dividend Yield | 0.51 |
| Payout Ratio | 0.21 |
| Last Split Factor | 513:500 |
| Last Split Date | October 20, 2017 |
AD
